Status:
ACTIVE_NOT_RECRUITING
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
Lead Sponsor:
Malmö University
Collaborating Sponsors:
Skane University Hospital
University of Copenhagen
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
40+ years
Phase:
PHASE2
PHASE3
Brief Summary
The investigators want to study the effect of clobetasol in symptomatic oral lichen planus. The investigators will include 90 patients and randomly allocate them in three groups. The first group will ...
Eligibility Criteria
Inclusion
- Symptomatic oral lichen planus
- Age above 40 years
Exclusion
- Lichenoid contact lesions
- Graft versus host disease
- Bacteria related lichenoid reaction
- Intraoral vesiculobullous diseases
- Active antibiotic treatment
- Active treatment with steroids or other immunomodulating substance
- Allergy to Clobetasol
- Severe periodontitis
- Bad oral hygiene
- Biopsy not supporting OLP
- Allergy to nystatin
- Not in menopause
- Previous or actual oral malignancy
- Participation in other medical study
Key Trial Info
Start Date :
May 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04364555
Start Date
May 18 2020
End Date
December 1 2025
Last Update
December 4 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oral surgery, Universityhospital of Scania
Lund, Sweden, 22242
2
Oral Surgery and oral medicine, Malmö University
Malmo, Sweden, 20506